TLDR ARK Invest purchased 781,519 Joby Aviation shares worth $10.4 million on January 29, 2026, following a 16.7% stock decline Joby Aviation announced a $1 billionTLDR ARK Invest purchased 781,519 Joby Aviation shares worth $10.4 million on January 29, 2026, following a 16.7% stock decline Joby Aviation announced a $1 billion

Why Cathie Wood Bought Joby Aviation Stock During Thursday’s 16% Crash

3 min read

TLDR

  • ARK Invest purchased 781,519 Joby Aviation shares worth $10.4 million on January 29, 2026, following a 16.7% stock decline
  • Joby Aviation announced a $1 billion capital raise through common stock and convertible notes, triggering investor dilution concerns
  • ARK sold 31,668 Teradyne shares for $7.9 million as the stock reached $253.61 amid joint venture news with MultiLane
  • CRISPR Therapeutics received $6.8 million investment from ARK with purchase of 127,184 shares across multiple ETFs
  • ARK reduced holdings in Veracyte and Illumina while making smaller adjustments to Beam Therapeutics and Kratos Defense positions

Cathie Wood’s ARK Invest executed multiple trades on January 29, 2026, with the largest transaction targeting electric aviation company Joby Aviation. The investment firm disclosed these moves through its daily fund updates.

ARK purchased 781,519 shares of Joby Aviation for a total value of $10.4 million. The shares were acquired through two ETFs: ARK Autonomous Technology & Robotics ETF and ARK Space Exploration & Innovation ETF.


JOBY Stock Card
Joby Aviation, Inc., JOBY

The purchase came after Joby Aviation stock fell 16.7% in a single trading session. The decline followed the company’s announcement of a major capital raise. Joby plans to raise approximately $1 billion through a combination of common stock sales and convertible senior notes maturing in 2032.

Market participants expressed concern about potential shareholder dilution from the capital raise. ARK took advantage of the lower price point to increase its position in the air taxi developer.

Gene-Editing Investment Grows

ARK expanded its biotech holdings with a CRISPR Therapeutics stock purchase. The firm acquired 127,184 shares valued at $6.8 million. The transaction occurred across the ARKK and ARKG ETFs.

This purchase represents a continuation of ARK’s buying activity in CRISPR Therapeutics. The firm has been steadily accumulating shares over multiple trading sessions. The gene-editing company’s stock experienced a minor decline during Thursday’s trading.

Semiconductor Position Reduced

ARK Invest divested 31,668 shares of Teradyne for proceeds of $7.9 million. The sale was executed through the ARKQ and ARKX ETFs. Teradyne stock hit an intraday peak of $253.61 during the session.

The sale timing aligned with positive company news. Teradyne and MultiLane announced the formation of a joint venture called MultiLane Test Products. The partnership will address growing demand for high-speed data connection testing in artificial intelligence data centers.

Under the agreement, MultiLane will transfer its test and measurement assets to the new entity. MultiLane retains control of its interconnects and data center test operations. Teradyne will maintain majority ownership of the joint venture.

Additional Portfolio Changes

ARK sold 31,463 Veracyte shares through its ARKK ETF, generating $1.2 million. The firm also decreased its Illumina position by 35,897 shares across ARKK and ARKG. These sales extend ARK’s recent divestment pattern in both companies.

The firm made smaller trades including a 29,413-share purchase of Beam Therapeutics. ARK also sold 261 shares of Kratos Defense and Security Solutions. Wall Street analysts assign a “Moderate Buy” rating to both Teradyne and CRISPR Therapeutics, while Joby Aviation carries a “Hold” rating with projected 41% upside over twelve months.

The post Why Cathie Wood Bought Joby Aviation Stock During Thursday’s 16% Crash appeared first on Blockonomi.

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.
Tags:

You May Also Like

CME Group to launch Solana and XRP futures options in October

CME Group to launch Solana and XRP futures options in October

The post CME Group to launch Solana and XRP futures options in October appeared on BitcoinEthereumNews.com. CME Group is preparing to launch options on SOL and XRP futures next month, giving traders new ways to manage exposure to the two assets.  The contracts are set to go live on October 13, pending regulatory approval, and will come in both standard and micro sizes with expiries offered daily, monthly and quarterly. The new listings mark a major step for CME, which first brought bitcoin futures to market in 2017 and added ether contracts in 2021. Solana and XRP futures have quickly gained traction since their debut earlier this year. CME says more than 540,000 Solana contracts (worth about $22.3 billion), and 370,000 XRP contracts (worth $16.2 billion), have already been traded. Both products hit record trading activity and open interest in August. Market makers including Cumberland and FalconX plan to support the new contracts, arguing that institutional investors want hedging tools beyond bitcoin and ether. CME’s move also highlights the growing demand for regulated ways to access a broader set of digital assets. The launch, which still needs the green light from regulators, follows the end of XRP’s years-long legal fight with the US Securities and Exchange Commission. A federal court ruling in 2023 found that institutional sales of XRP violated securities laws, but programmatic exchange sales did not. The case officially closed in August 2025 after Ripple agreed to pay a $125 million fine, removing one of the biggest uncertainties hanging over the token. This is a developing story. This article was generated with the assistance of AI and reviewed by editor Jeffrey Albus before publication. Get the news in your inbox. Explore Blockworks newsletters: Source: https://blockworks.co/news/cme-group-solana-xrp-futures
Share
BitcoinEthereumNews2025/09/17 23:55
BlockchainFX or Based Eggman $GGs Presale: Which 2025 Crypto Presale Is Traders’ Top Pick?

BlockchainFX or Based Eggman $GGs Presale: Which 2025 Crypto Presale Is Traders’ Top Pick?

Traders compare Blockchain FX and Based Eggman ($GGs) as token presales compete for attention. Explore which presale crypto stands out in the 2025 crypto presale list and attracts whale capital.
Share
Blockchainreporter2025/09/18 00:30
XRP Price Enters Reset Phase as Key Indicator Hits Extreme Lows

XRP Price Enters Reset Phase as Key Indicator Hits Extreme Lows

XRP trades at $1.567 with RSI at 27.03, indicating oversold conditions and potential short-term bounce ahead. EGRAG CRYPTO identifies this as a reset phase, not
Share
LiveBitcoinNews2026/02/05 02:30